MPM
AZN icon

MBB Public Markets’s AstraZeneca AZN Stock Holding History

MBB Public Markets’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,278
Closed -$580K – 693
2024
Q1 		$580K Buy
+4,278
New +$566K 0.04% 135
2022
Q1 		– Sell
-13,023
Closed -$1.52M – 118
2021
Q4 		$1.52M Buy
+13,023
New +$1.53M 0.03% 91

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

MBB Public Markets's AZN Position: Q2 2024 in Review

MBB Public Markets sold out of AstraZeneca (AZN) in Q2 2024, closing a stake of 4,278 shares — an estimated $580K sold.

MBB Public Markets first reported a position in AZN in Q4 2021 and held it in 2 quarters. The position peaked at $1.52M in Q4 2021. 1,212 funds tracked by Wall St. Rank hold AZN as of Q2 2024.

  • MBB Public Markets reported no remaining AstraZeneca position as of Q2 2024 after selling out during the quarter.
  • MBB Public Markets sold 4,278 AstraZeneca shares in Q2 2024, an estimated $580K.
  • MBB Public Markets first reported a position in AstraZeneca in Q4 2021 and held it in 2 quarters.
  • MBB Public Markets's AstraZeneca position peaked at $1.52M in Q4 2021.
  • 1,212 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2024.

Based on MBB Public Markets's 13F filing for Q2 2024, filed 14 Aug 2024.